Hqn-FT Cream contains Fluocinolone Acetonide, Hydroquinone, and Tretinoin, a triple-combination topical medicine commonly used for the treatment of melasma and other hyperpigmented skin conditions where inflammation, excess melanin production, and uneven skin turnover contribute to discolouration. Fluocinolone Acetonide is a mild corticosteroid that reduces irritation and inflammation, Hydroquinone is a depigmenting agent that decreases melanin formation, and Tretinoin is a retinoid that promotes skin cell turnover and enhances penetration of the other active ingredients. Together, they help improve skin tone, lighten dark patches, and support gradual skin renewal. This combination should be used only under medical supervision and exactly as prescribed.
Last updated on: 06-05-2026
WHO GMP Certified
Long Expiry (>8 Months)
15 Days Easy Returns
Genuine Medicine
Pay On Delivery
Secure Payment
LegitScript Certified Online Pharmacy
View content in
Hqn-FT Cream contains Fluocinolone Acetonide, Hydroquinone, and Tretinoin, a triple-combination topical medicine commonly used for the treatment of melasma and other hyperpigmented skin conditions where inflammation, excess melanin production, and uneven skin turnover contribute to discolouration. Fluocinolone Acetonide is a mild corticosteroid that reduces irritation and inflammation, Hydroquinone is a depigmenting agent that decreases melanin formation, and Tretinoin is a retinoid that promotes skin cell turnover and enhances penetration of the other active ingredients. Together, they help improve skin tone, lighten dark patches, and support gradual skin renewal. This combination should be used only under medical supervision and exactly as prescribed.
Hqn-FT Cream is a dermatological fixed-dose combination designed to manage melasma, post-inflammatory hyperpigmentation, and selected pigmentary disorders by targeting multiple pathways involved in skin pigmentation.
Fluocinolone Acetonide is a low-potency topical corticosteroid that suppresses local inflammatory mediators such as prostaglandins and cytokines. In pigmentary disorders, inflammation often worsens melanocyte activity and causes irritation during active depigmenting therapy. Fluocinolone helps reduce redness, burning, and irritation associated with treatment while improving tolerability.
Hydroquinone is a depigmenting agent that inhibits the enzyme tyrosinase, which plays a key role in melanin synthesis. By reducing melanin production in melanocytes, Hydroquinone gradually lightens dark patches and uneven pigmentation. It is one of the most widely used topical depigmenting agents in clinical dermatology.
Tretinoin is a retinoid derived from vitamin A that increases epidermal cell turnover, promotes shedding of pigmented keratinocytes, and improves penetration of Hydroquinone into deeper skin layers. It also helps reduce epidermal thickening and supports smoother skin texture.
The triple combination is considered highly effective because it addresses inflammation, melanin production, and epidermal renewal simultaneously. However, because skin sensitivity may occur, treatment is generally prescribed for controlled durations with careful sun protection.
This medicine is usually applied once daily at night in a thin layer over affected skin only.
The uses of Hqn-FT Cream are as follows:
Helps lighten facial dark patches caused by hormonal changes or sun exposure.
Improves pigmentation left after acne or skin inflammation.
Helps improve localised pigment irregularities.
Used in selected pigment disorders under dermatological guidance.
Supports gradual reduction of UV-induced dark patches.
Here are the benefits of Hqn-FT Cream:
Like all medicines, Hqn-FT Cream may cause side effects in some individuals, especially during early treatment.
Always consult your doctor if side effects persist or worsen.
To ensure safe and effective use:
Hqn-FT Cream works through three complementary mechanisms that target pigmentation and skin inflammation.
Fluocinolone Acetonide suppresses inflammatory mediators in the skin, reducing redness, irritation, and inflammatory stimulation of melanocytes.
Hydroquinone inhibits tyrosinase, the enzyme required for melanin synthesis, thereby reducing pigment formation within melanocytes.
Tretinoin increases epidermal turnover, accelerates shedding of pigmented cells, and improves penetration of Hydroquinone into the epidermis.
Together, these actions help lighten hyperpigmented lesions gradually while improving skin texture.
As Hqn-FT Cream is intended for topical use, significant food interactions are unlikely. However:
Hqn-FT Cream may interact with:
Hqn-FT Cream should be used carefully in:
The dose depends on severity and area involved. Usually applied once daily at night in a very thin layer as prescribed by your doctor.
If you miss an application, apply it when remembered unless the next application is due soon. Do not apply extra quantity.
Therapeutic Class
Dermatology
Action Class
Topical Triple Depigmenting Combination
Chemical Class
Corticosteroid + Depigmenting Agent + Retinoid
Habit Forming
No
PlatinumRx is committed to providing reliable and accurate information to support informed customer decisions. However, all information made available on the Platform, including product descriptions, comparisons, and other content, is provided solely for general informational purposes. Such information is not intended to diagnose, prevent, treat, or cure any medical condition, nor should it be relied upon as a substitute for professional medical advice, diagnosis, or treatment.

More Medicines By Manufacturer
More Medicines With Salt
Top Selling Medicines
Top Selling Devices